Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells

Published:2012-01 Issue:1 Volume:75 Page:95-101
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tao Hiroyuki,Mimura Yusuke,Aoe Keisuke,Kobayashi Seiki,Yamamoto Hiromasa,Matsuda Eisuke,Okabe Kazunori,Matsumoto Tsuneo,Sugi Kazurou,Ueoka Hiroshi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I–IIIA resectable non small-cell lung cancer guideline;Pisters;J Clin Oncol,2007

3. Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future;Potti;Expert Opin Biol Ther,2006

4. Polarized immune responses differentially regulate cancer development;Johansson;Immunol Rev,2008

5. Immunity, inflammation, and cancer;Grivennikov;Cell,2010

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer;Journal of Translational Medicine;2024-07-30

2. Identification and validation of potential common biomarkers for papillary thyroid carcinoma and Hashimoto’s thyroiditis through bioinformatics analysis and machine learning;Scientific Reports;2024-07-06

3. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma;Cancer Letters;2024-05

4. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer;Genes;2024-04-15

5. Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration;BMC Cancer;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3